PanGenomic Health (XCNQ:NARA) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. PanGenomic Health's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

PanGenomic Health's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

PanGenomic Health LT-Debt-to-Total-Asset Historical Data

The historical data trend for PanGenomic Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health LT-Debt-to-Total-Asset Chart

PanGenomic Health Annual Data

Trend

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

PanGenomic Health Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial									-	-	-	-	-

PanGenomic Health LT-Debt-to-Total-Asset Calculation

PanGenomic Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0	/	0.071
	=

PanGenomic Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0	/	0.063
	=

PanGenomic Health (XCNQ:NARA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

PanGenomic Health LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

PanGenomic Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

LL3:Germany

Address

3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9

Website

https://www.pangenomic.com

PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.

Executives

Kaidong Zhang	Senior Officer
Vincent Lum	Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer

PanGenomic Health Headlines

No Headlines